Search

Your search keyword '"Eslam M"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Eslam M" Remove constraint Author: "Eslam M" Publisher elsevier Remove constraint Publisher: elsevier
41 results on '"Eslam M"'

Search Results

1. The role of relative humidity and cement type on carbonation resistance of concrete

2. The role of MgBr2 to enhance the ionic conductivity of PVA/PEDOT:PSS polymer composite

3. Tissue-specific analysis of Coffea arabica L. transcriptome revealed potential regulatory roles of lncRNAs

4. Paecilomyces sp. ZB is a cell factory for the production of gibberellic acid using a cheap substrate in solid state fermentation

5. Remote sensing of 10 years changes in the vegetation cover of the northwestern coastal land of Red Sea, Saudi Arabia

6. Effects of 4-CPPU on in vitro multiplication and sustainable generation of Hibiscus rosa-sinensis L. ‘White Butterfly’

7. Seasonal dynamics and ecological risks of organochlorine pesticides in Kafrelsheikh-Egypt: Implications for aquatic ecosystems and public health

8. Knowledge, attitudes, and practices regarding brucellosis in a rural population: A cross-sectional study

9. Efficient and reproducible in vitro regeneration of Solanum lycopersicum and assessment genetic uniformity using flow cytometry and SPAR methods

10. Two-way shear full behavior of reinforced concrete flat slabs under membrane tensile forces

11. Monitoring of morphological, biochemical and molecular responses of four contrasting barley genotypes under salinity stress

12. Biological indicators for environmental quality monitoring of marine sediment in Suez Gulf, Egypt

13. Endoscopic stapedotomy: Merits and demerits

14. Real time adaptive probabilistic recurrent Takagi-Sugeno-Kang fuzzy neural network proportional-integral-derivative controller for nonlinear systems.

15. Synthesis, insecticidal Activity, and molecular docking analysis of some benzo[h]quinoline derivatives against Culex pipiens L. Larvae.

18. Post-Liver Transplant Metabolic Syndrome.

20. Rational design and eco-friendly one-pot multicomponent synthesis of novel ethylidenehydrazineylthiazol-4(5H)-ones as potential apoptotic inducers targeting wild and mutant EGFR-TK in triple negative breast cancer.

21. A highly selective bulk optode based on 6-{4-(2,4-dihydroxy-phenyl)diazenyl)phenyl}-2-oxo-4-phenyl-1,2-dihydro-pyridine-3-carbonitrile incorporating chromoionophore V for determination of nano levels of cadmium.

22. Effect of N-acetylcysteine on attenuation of chlropyrifos and its methyl analogue toxicity in male rats.

23. MAFLD: Now is the time to capitalize on the momentum.

24. MAFLD: A game changer redefining fatty liver disease for adults and children.

25. MAFLD: A holistic view to redefining fatty liver disease.

26. Yet more evidence that MAFLD is more than a name change.

27. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF V600E inhibitors.

28. Reply to: correspondence regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement": Bringing evidence to the NAFLD-MAFLD debate.

29. Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practice.

30. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.

31. Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening.

32. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

34. Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors.

35. Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity.

36. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.

37. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.

38. Genetics and epigenetics of NAFLD and NASH: Clinical impact.

39. FibroGENE: A gene-based model for staging liver fibrosis.

40. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.

41. Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

Catalog

Books, media, physical & digital resources